Xerostomia Pilot Fudan: Acupuncture for Prevention of Radiation-Induced Xerostomia
Not Applicable
- Conditions
- XerostomiaHead and Neck Cancer
- Interventions
- Other: Acupuncture
- First Posted Date
- 2009-03-17
- Last Posted Date
- 2020-12-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT00862550
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
Completed
- Conditions
- Stage IVB Lung Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Metastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the LungStage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8
- Interventions
- Procedure: 4-Dimensional Computed TomographyProcedure: 4D PET Scan
- First Posted Date
- 2009-03-17
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00862680
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine
Phase 1
Completed
- Conditions
- Melanoma
- Interventions
- Drug: Pegylated Interferon-Alfa 2b (PEG Intron)Drug: GP-100 Peptide Vaccine
- First Posted Date
- 2009-03-13
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 38
- Registration Number
- NCT00861406
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Phase 2
Completed
- Conditions
- LeukemiaLymphomaStem Cell Transplantation
- Interventions
- Drug: ThiotepaDrug: ClofarabineDrug: BusulfanProcedure: Allogeneic Stem Cell TransplantationDrug: Thymoglobulin (ATG)Drug: G-CSF (Filgrastim)Drug: TacrolimusDrug: MethotrexateDrug: CyclophosphamideDrug: Mesna
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT00857389
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Expressive Disclosure and Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Behavioral: InterviewsBehavioral: QuestionnairesBehavioral: Group MeetingsOther: Electronically Activated Recorder (EAR)Behavioral: Written Materials
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 174
- Registration Number
- NCT00853203
- Locations
- 🇺🇸
Kelsey-Seybold Clinics, Houston, Texas, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 146
- Registration Number
- NCT00850941
- Locations
- 🇺🇸
Kaseman Presbyterian Hospital, Albuquerque, New Mexico, United States
🇺🇸Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
- Conditions
- Advanced Cancers
- Interventions
- Other: Molecular Profiling Analyses
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 5000
- Registration Number
- NCT00851032
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households
Not Applicable
Completed
- Conditions
- Cigarette SmokerCurrent SmokerCurrently Living With Smoker
- Interventions
- Behavioral: Smoking Cessation InterventionOther: Informational InterventionOther: Survey Administration
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 168
- Registration Number
- NCT00850954
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy
Not Applicable
Completed
- Conditions
- Gastrointestinal Cancer
- Interventions
- Behavioral: QuestionnaireOther: Interview
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 184
- Registration Number
- NCT00849979
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Genetic Susceptibility to Bladder Cancer
Active, not recruiting
- Conditions
- Bladder Cancer
- Interventions
- Behavioral: Interviews
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 6086
- Registration Number
- NCT00848289
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath